Cargando…
Effects of glucagon‐like peptide‐1 receptor agonists on kidney function and safety in type 2 diabetes patients
Glucagon‐like peptide‐1 receptor agonists have been recommended in diabetic kidney disease patients.[Image: see text]
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169368/ https://www.ncbi.nlm.nih.gov/pubmed/33759351 http://dx.doi.org/10.1111/jdi.13552 |
| _version_ | 1783702045996351488 |
|---|---|
| author | Kim, Min Kyung Kim, Doo‐Man |
| author_facet | Kim, Min Kyung Kim, Doo‐Man |
| author_sort | Kim, Min Kyung |
| collection | PubMed |
| description | Glucagon‐like peptide‐1 receptor agonists have been recommended in diabetic kidney disease patients.[Image: see text] |
| format | Online Article Text |
| id | pubmed-8169368 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81693682021-06-05 Effects of glucagon‐like peptide‐1 receptor agonists on kidney function and safety in type 2 diabetes patients Kim, Min Kyung Kim, Doo‐Man J Diabetes Investig Commentaries Glucagon‐like peptide‐1 receptor agonists have been recommended in diabetic kidney disease patients.[Image: see text] John Wiley and Sons Inc. 2021-05-07 2021-06 /pmc/articles/PMC8169368/ /pubmed/33759351 http://dx.doi.org/10.1111/jdi.13552 Text en © 2021 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Commentaries Kim, Min Kyung Kim, Doo‐Man Effects of glucagon‐like peptide‐1 receptor agonists on kidney function and safety in type 2 diabetes patients |
| title | Effects of glucagon‐like peptide‐1 receptor agonists on kidney function and safety in type 2 diabetes patients |
| title_full | Effects of glucagon‐like peptide‐1 receptor agonists on kidney function and safety in type 2 diabetes patients |
| title_fullStr | Effects of glucagon‐like peptide‐1 receptor agonists on kidney function and safety in type 2 diabetes patients |
| title_full_unstemmed | Effects of glucagon‐like peptide‐1 receptor agonists on kidney function and safety in type 2 diabetes patients |
| title_short | Effects of glucagon‐like peptide‐1 receptor agonists on kidney function and safety in type 2 diabetes patients |
| title_sort | effects of glucagon‐like peptide‐1 receptor agonists on kidney function and safety in type 2 diabetes patients |
| topic | Commentaries |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169368/ https://www.ncbi.nlm.nih.gov/pubmed/33759351 http://dx.doi.org/10.1111/jdi.13552 |
| work_keys_str_mv | AT kimminkyung effectsofglucagonlikepeptide1receptoragonistsonkidneyfunctionandsafetyintype2diabetespatients AT kimdooman effectsofglucagonlikepeptide1receptoragonistsonkidneyfunctionandsafetyintype2diabetespatients |